Rolling Out3d
Key signs that might indicate you have Crohn’s disease
Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...
MedPage Today on MSN1d
FDA Expands Guselkumab Approval to Crohn's Disease
The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, ...
Fierce Pharma1d
J&J advances Stelara succession scheme with FDA nod for Tremfya in Crohn's disease
With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...
GlobalData on MSN1d
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Johnson & Johnson (J&J) has received US Food and Drug Administration (FDA) approval for its interleukin 23 inhibitor, Tremfya ...
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
Johnson & Johnson's Tremfya gains FDA approval for Crohn's disease, backed by Phase 3 trial data and demonstrating ...
Immune cell dysfunction in GI tract may lead to onset of inflammatory bowel disease
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
Healio1d
Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara
The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...
Managed Healthcare Executive1d
FDA Approves Tremyfa to Treat Active Crohn’s Disease
Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...
Medscape3d
Can Ileocaecal Resection Cut Corticosteroid Use in Crohn's?
In patients with Crohn's disease and intermediate to high preoperative corticosteroid use, primary ileocaecal resection leads ...
MyChesCo on MSN7h
FDA Approves TREMFYA® for Crohn’s Disease, Offering New Treatment Options
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has announced that the U.S. Food and Drug Administration (FDA) has approved ...
KOAT Albuquerque3d
New treatments for Crohn's disease being studied
PRECAUTIONARY POWER SHUTOFFS IN ITS SERVICE AREA. WELL, CROHN’S DISEASE IS A TYPE OF INFLAMMATORY BOWEL DISEASE THAT AFFECTS AROUND 200,000 AMERICANS EVERY YEAR. KOAT. U-N-M HEALTH EXPERT DOCTOR ...